Y. Hong

Identification of alkylidene hydrazides as glucagon receptor antagonists.

A. Kuki, D. Murphy, A. Polinsky, 2001, Journal of medicinal chemistry.

Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase.

D. Deutsch, D. Ahern, R. Omeir, 1995, Life sciences.

Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo.

M. Michaelides, E. Bayburt, S. Didomenico, 1997, Journal of medicinal chemistry.

ABSORBANCE TRANSIENTS OF FERREDOXIN:NADP+ REDUCTASE IN ISOLATED THYLAKOID MEMBRANES

H. Matthijs, S. Coughlan, G. Garab, 1990 .

Tethered benzophenone reagents for the synthesis of photoactivatable ligands.

G. Prestwich, G. Dormán, J. Elliott, 1995, Bioconjugate chemistry.

(5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431).

M. Michaelides, M. Williams, S. Didomenico, 1995, Journal of medicinal chemistry.

Analysis of the Induction Phenomena in Initial PSP

Y. Hong, B. Guo, Z. Du, 1987 .

Design, synthesis, and structure-activity relationships of novel imidazo[4,5-c]pyridine derivatives as potent non-nucleoside inhibitors of hepatitis C virus NS5B.

P. Gong, Yingxiu Li, Yajing Liu, 2018, Bioorganic & medicinal chemistry.

ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.

L. Mahan, M. Michaelides, P. Jenner, 1996, The Journal of pharmacology and experimental therapeutics.